Copper drug clears Alzheimer's proteins and restores memory
Scientists have discovered that a copper-based compound can restore the brain's natural ability to clear toxic Alzheimer's proteins. In laboratory experiments, the treatment dramatically reduced amyloid buildup and improved memory function. The findings, reported in ScienceDaily, point to a potentially fast-tracked treatment approach for the neurodegenerative disease that affects millions worldwide. Researchers say the compound targets the brain's waste-clearing mechanism rather than directly attacking plaques.
GLP-1 drugs show unexpected cancer and bone benefits
Two large studies published this week reveal new health benefits of GLP-1 drugs. A study tracking women taking Ozempic, Wegovy, Mounjaro, and Zepbound found they were about 30% less likely to develop breast cancer. Separately, semaglutide (Ozempic, Wegovy) was linked to stronger protection against bone fractures in people with type 2 diabetes, despite delivering greater weight loss. However, researchers also found that people taking GLP-1 drugs started moving less, raising questions about muscle preservation during weight loss.
AI-designed universal coronavirus vaccine passes first human trial
An AI-designed universal coronavirus vaccine has successfully passed its first human trial, proving safe and well-tolerated. The vaccine generated immune responses against multiple coronavirus variants, offering hope for a pan-coronavirus vaccine that could protect against future strains and new outbreaks. The trial marks the first time an AI-designed vaccine has been tested in humans, opening a new frontier in vaccine development.